PODD Stock Analysis: Buy, Sell, or Hold?
PODD - Insulet Corporation
$164.48
4.69 (2.94%)
▲
5d:
+6.93%
30d:
+15.48%
90d:
-20.56%
HOLD
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When PODD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: PODD shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: PODD shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$391.09
Based on 14.4% avg growth
INTRINSIC VALUE TODAY
$242.84
32.3% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PODD is currently trading at $164.48, which is considered extended relative to its 30-day fair value range of $143.67 to $155.94. From a valuation perspective, the stock is trading at a discount (Forward PE: 20.4) compared to its historical average (31.4). Remarkably, the market is currently pricing in an annual earnings decline of 13.5% over the next few years. This pessimistic expectation contrasts with the company's recent 159.0% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, PODD is in a strong downtrend. The price is approaching resistance at $167.82. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: PODD has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $240.25 (+46.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PODD is in a strong downtrend. The price is approaching resistance at $167.82. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: PODD has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $240.25 (+46.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$143.67 -
$155.94
Company Quality Score
65/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
57.1%
Protect Your Profits
Holding PODD? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+5.5% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 46.1% below Wall St target ($240.25)
Trading Range Analysis
30-Day Trading Range
$143.67 -
$155.94
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$138.79
Resistance Level
$167.82
Current Trend
Strong Downtrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
20.35
Wall Street Target
$240.25
(+46.1%)
Revenue Growth (YoY)
33.9%
Earnings Growth (YoY)
159.0%
Profit Margin
10.4%
Valuation Discount vs History
-13.5% cheaper
PE vs Historical
20.4 vs 31.4
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-13.5%
(market-implied from PE analysis)
1-Year Target
$148.03
(-10%)
2-Year Target
$133.23
(-19%)
3-Year Target
$119.91
(-27%)
3-Yr Target (if PE normalizes)
(PE: 20→31)
$185.05
(+13%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 24.7%)
$341.61
(+108%)
Base:
(SPY PE: 20.3, Growth: 24.7%)
$319.13
(+94%)
Bear:
(PE: 17.3, Growth: 24.7%)
$271.26
(+65%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (37x PE), but valuation improves significantly next year (20x PE) as earnings recover.
Trailing PE: 37.33 | Current EPS (TTM): $4.28
Bull Case
$331.99
(+102%)
Analyst growth 88.9%, PE expands to 41.1
Base Case
$301.81
(+84%)
Market implied 88.9%, PE stable at 37.3
Bear Case
$108.66
(-34%)
Severe decline -20.0%, PE contracts to 31.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 20.3 to 31.4
Stabilization Target:
$253.83
(+54.3%)
PE Expansion Potential:
+54.3%
Share & Embed Analysis
Last updated: July 04, 2026 4:09 PM ET
Data refreshes hourly during market hours. Next update: 5:09 PM
Data refreshes hourly during market hours. Next update: 5:09 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PODD showing a specific setup today?
Insider Activity (6 Months)
2
Buys
1
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Michael R Minogue
BUY
2030 shares
2026-02-25
Ro Khanna
SELL
2026-02-24
Ro Khanna
BUY
2026-02-17
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$75 | 65 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 58 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 63 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 65 BUY |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$80 | 65 BUY |
Advanced PODD Option Strategies
Professional options setups generated by AI based on today's PODD price and gamma walls.
